Business Standard

Eli Lilly plans $ 850 million investment for expansion in US

To invest $85 mn to expand its Trulicity (dulaglutide) device assembly operations in Indianapolis

Eli Lilly office
Premium

Eli Lilly office

BS B2B Bureau Indianapolis, USA
Eli Lilly and Company will invest $ 850 million for expansion of its US operations - spanning facilities across its US enterprise, including research laboratories, manufacturing sites, and general and administrative areas - in 2017. The investments are being driven by demand for Lilly products, as well as its robust pipeline of potential medicines in development targeting cancer, pain, diabetes and other unmet medical needs. 

Company leaders were joined by federal, state and local government officials at Lilly Technology Center on March 24, 2017, where the details of the investments were unveiled, including plans for a new $ 85 million expansion

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in